Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Gilead_Sciences
|
| gptkbp:acquisitionYear |
2013
|
| gptkbp:country |
gptkb:Canada
|
| gptkbp:focus |
oncology
|
| gptkbp:founded |
1994
|
| gptkbp:headquarters_location |
Mississauga, Ontario, Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
YM BioSciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:nimotuzumab
CYT387 |
| gptkbp:tradedOn |
NYSE: YMI
TSX: YM |
| gptkbp:website |
www.ymbiosciences.com
|
| gptkbp:bfsParent |
gptkb:Sierra_Oncology
|
| gptkbp:bfsLayer |
8
|